Raplixa (ProFibrix BV)
Welcome to the PulseAid listing for the Raplixa drug offered from ProFibrix BV. This Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | ProFibrix BV |
| NON-PROPRIETARY NAME: | fibrinogen human and thrombin human |
| SUBSTANCE NAME: | FIBRINOGEN HUMAN; HUMAN THROMBIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | POWDER |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-06-22 |
| END MARKETING DATE: | 0000-00-00 |
Raplixa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Raplixa from ProFibrix BV |
| LABELER NAME: | ProFibrix BV |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 79; 699(mg/g; [iU]/g) |
| START MARKETING DATE: | 2015-06-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62238-008_f8914933-9399-40fc-963f-f2f8e87a5a02 |
| PRODUCT NDC: | 62238-008 |
| APPLICATION NUMBER: | BLA125523 |
Other FIBRINOGEN HUMAN; HUMAN THROMBIN Pharmaceutical Manufacturers / Labelers:
